Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
algorithm
analgesic
atogepant
calcitonin gene related peptide
calcitonin gene-related peptide receptor blocker
CAT scan
children
cluster headache
complications
cost
dementia, autoimmune
diagnostic criteria
efficacy
eletriptan
epidemiology of neurology
eptinezumab
erenumab
fremanezumab
galcanezumab
headache
headache, preventive treatment
headache, recurrent
migraine
migraine, children
migraine, chronic
migraine, intractable
migraine, pathogenesis
migraine, prophylaxis
migraine, treatment of
monoclonal antibodies
narcotic analgesics
neurologic disease, diagnoses of
nonsteroidal anti-inflammatory drug
prevention of neurologic disorders
quality of life
recurrent
review article
rimegepant
safety
serotonin agonist
serotonin antagonist
sumatriptan
telcagepant
topiramate
treatment of neurologic disorder
treatment resistant
trigeminovascular system
triptans
ubrogepant
Showing articles 400 to 450 of 1206 << Previous Next >>

Treatment of ?-Aminobutyric Acid� Receptor-Antibody Autoimmune Encephalitis with Oral Corticosteroids
Arch Neurol 69:1061-1063, Goldenholz, D.M.,et al, 2012

Anti-Glutamic Acid Decarboxylase Limbic Encephalitis Without Epilepsy Evolving Into Dementia with Cerebellar Ataxia
Arch Neurol 69:1064-1066, Mirabelli-Badenier, M.,et al, 2012

Hemostatic Therapy Should be Used for Acute Treatment of Anticoagulation-Related Intracerebral Hemorrhage
Stroke 43:2535-2536,2539, Diringer, M. & Zazulia, A.R., 2012

Hemostatic Therapy Should not be Used for Acute Treatment of Anticoagulation-Related Intracerebral Hemorrhage
Stroke 43:2537-2538,2539, Stapf, C., 2012

Clinicopathologic Conference, Paraneoplastic Stiff Person Syndrome with Limbic Encephalitis with Anti-Amphiphysin Antibodies with Metastatic Carcinoma of Breast
NEJM 367:851-861, Case 27-2012, 2012

Do We Have to Stop Anticoagulant and Platelet-Inhibitor Treatments During Proctological Surgery?
Colorectal Dis 14:16-20, Pigot, F.,et al, 2012

Using Dabigatran in Patients with Stroke A Practical Guide for Clinicians
Stroke 43:271-279, Alberts, M.J.,et al, 2012

New Antithrombotic Drugs for Atrial Fibrillation: Caution is Needed
Lancet 379:e24, Bell,S.,et al, 2012

Stiff-Man Syndrome and Variants
Arch Neurol 69:230-238, McKeon,A.,et al, 2012

Cost-Effectiveness of Dabigatran Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
Stroke 43:881-883, Kamel,H.,et al, 2012

Critique of Apixaban Versus Warfarin in Patients with Atrial Fibrillation
Stroke 43:922-923, Nedeltchev,K, 2012

Patent Foramen Ovale Closure and Medical Treatments for Secondary Stroke Prevention
Stroke 43:422-431, Kitsios,G.D.,et al, 2012

Anticoagulant Loses its Lustre
Lancet 379:301, Mullar,A., 2012

Rivaroxaban versus Warfarin in Nonvavular Atrial Fibrillation
NEJM 365:883-891, 952, Patel, M.R.,et al, 2011

Apixaban versus Warfarin in Patients with Atrial Fibrillation
NEJM 365:981-992,1052, Granger, C.B.,et al, 2011

Autoimmune Limbic Encephalitis with GAD Antibodies
The Neurohospitalist 1:178-181, Finelli, P.F., 2011

Clinicopathologic Conference, Limbic Encephaitis with Antibodies to Leucine - Rich Glioma - inactivated 1 (LGI 1).
NEJM 365:1825-1833, Case 34-2011, 2011

Paraneoplastic and Autoimmune Encephalitis
UpToDate, June, Dalmau, J.,et al, 2011

Dabigatran Etexilate versus Warfarin in Management of Non-Valvular Atrial Fibrillation in UK Context: Quantitative Benefit-Harm and Economic Analyses
BMJ 343:d6333, Pink, J.,et al, 2011

A New Landscape for Stroke Prevention in Atrial Fibrillation
Stroke 42:3316-3322, Banerjee, A.,et al, 2011

Warfarin-Related Intraventricular Hemorrhage
Neurol 77:1840-1846, Biffi, A.,et al, 2011

Whipple Limbic Encephalitis
Arch Neurol 68:1471-1473, Blanc, F.,et al, 2011

Resumption of Oral Anticoagulation After Warfarin-Associated Intracerebral Hemorrhage
Stroke 42:3661-3662, 3665, Steiner, T., 2011

Resumption of Oral Anticoagulation After Warfarin-Associated Intracereral Hemorrhage
Stroke 42:3663-3664, 3665, Schulman, S., 2011

Clinicopathologic Conference, Thymoma with Paraneoplastic Myasthenia Gravis, Polymyositis and Myocarditis, and Brain Stem Encephalitis
NEJM 365:2413-2422, Case 39-2011, 2011

Apixaban in Atrial Fibrillation From Bleeding Cows to 21st Century Medicinal Chemistry
Stroke 42:2376-2378, Cucchiara, B.L.,et al, 2011

Subtherapeutic International Normalized Ratio in Warfarin-Treated Patients Increases the Risk for Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis
Stroke 42:2333-2335, Seet, R.C.S.,et al, 2011

Posterior cerebral artery susceptibility vessel sign on T2*-weighted gradient echo imaging
Neurol 77:e25, Roh, J.H.,et al, 2011

Improved Late Survival and Disability After Stroke With Therapeutic Anticoagulation for Atrial Fibrillation
Stroke 42:2503-2508, Hannon, N.,et al, 2011

Extended-Release Pramipexole in Advanced Parkinson Disease
Neurol 77:767-774, Schapira, A.H.V.,et al, 2011

Encephalitis Associated with Glutamic Acid Decarboxylase Autoantibodies in a Child A Treatable Condition?
Arch Neurol 68:1065-1068, Korff, C.M.,et al, 2011

Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011

A Case of Hashimoto Encephalopathy Clinical Manifestation, Imaging, Pathology, Treatment, and Prognosis
The Neurologist 17:141-143, Zhao, W.,et al, 2011

Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force
Eur J Neurol 18:19-27, Titulaer, M.J.,et al, 2011

Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data
Pharmacol Ther 129:185-194, Terry, K.W.,et al, 2011

Random skin biopsy and bone marrow biopsy for diagnosis of intravascular large B cell lymphoma
Ann Hematol 90:417-421, Matsue, K.,et al, 2011

VGKC antibodies in pediatric encephalitis presenting with status epilepticus
Neurology 76:1252-1255, Suleiman, J.,et al, 2011

Cost Effectiveness of Warfarin Versus Aspirin in Patients Older Than 75 Years With Atrial Fibrillation
Stroke 42:1717-1721, Jowett, S.,et al, 2011

Rhombencephalitis A Series of 97 Patients
Medicine 90:256-261, Moragas, M.,et al, 2011

Apixaban in Patients With Atrial Fibrillation
NEJM 364:806-817, Connolly,S.J.,et al, 2011

The Evaluation of Rapidly Progressive Dementia
The Neurologist 17:67-74, Rosenbloom,M.H. &Atri,A., 2011

GABAB Receptor Antibodies in Limbic Encephalitis and Anti-GAD-Associated Neurologic Disorders
Neurol 76:795-800, Boronat,A.,et al, 2011

Spectrum of Paraneoplastic Disease Associated With Lymphoma
Neurol 76:705-710, Briani,C.,et al, 2011

Subtherapeutic Warfarin Is Not Associated With Increased Hemorrhage Rates in Ischemic Strokes Treated With Tissue Plasminogen Activator
Stroke 42:1041-1045, Vergouwen,M.D.I.,et al, 2011

Cost Efficiency of Anticoagulation With Warfarin to Prevent Stroke in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation
Stroke 42:112-118, Mercaldi,C.J.,et al, 2011

New Alternative to Warfarin May Help Reduce Stroke Risk in Patients With AF
JAMA 305:25-26, Mitka,M., 2011

Autoimmune Encephalopathy
Semin Neurol 31:144-157, Flanagan, E.,et al, 2011

Hashimotos Encephalopathy
Radiol Case Reports 6:445-449, Ramalho, J. & Castillo, M., 2011

Atypical Dementia
Lancet 376:656, Cohen-Bittan,J. et al, 2010

Effect of Home Testing of International Normalized Ratio on Clinical Events
NEJM 363:1608-1620, Matchar,D.B.,et al, 2010



Showing articles 400 to 450 of 1206 << Previous Next >>